<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">77969</article-id><article-id pub-id-type="doi">10.7554/eLife.77969</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group><subj-group subj-group-type="heading"><subject>Medicine</subject></subj-group></article-categories><title-group><article-title>Immune dynamics in SARS-CoV-2 experienced immunosuppressed rheumatoid arthritis or multiple sclerosis patients vaccinated with mRNA-1273</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-123658"><name><surname>Verstegen</surname><given-names>Niels JM</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5732-4979</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-271327"><name><surname>Hagen</surname><given-names>Ruth R</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-271328"><name><surname>van den Dijssel</surname><given-names>Jet</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4849-0374</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-271329"><name><surname>Kuijper</surname><given-names>Lisan H</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3009-0943</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-271330"><name><surname>Kreher</surname><given-names>Christine</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-271331"><name><surname>Ashhurst</surname><given-names>Thomas</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7269-7773</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-271332"><name><surname>Kummer</surname><given-names>Laura YL</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-271333"><name><surname>Steenhuis</surname><given-names>Maurice</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-271334"><name><surname>Duurland</surname><given-names>Mariel</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-271335"><name><surname>Jongh</surname><given-names>Rivka de</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-271336"><name><surname>Jong</surname><given-names>Nina de</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-254223"><name><surname>van der Schoot</surname><given-names>Ellen</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-271337"><name><surname>Bos</surname><given-names>Amélie V</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-271338"><name><surname>Mul</surname><given-names>Erik</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-40421"><name><surname>Kedzierska</surname><given-names>Katherine</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6141-335X</contrib-id><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-286313"><name><surname>van Dam</surname><given-names>Peter J</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-271340"><name><surname>Stalman</surname><given-names>Eileen W</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-271341"><name><surname>Boekel</surname><given-names>Laura</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-271342"><name><surname>Wolbink</surname><given-names>Gertjan L</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-271343"><name><surname>Tas</surname><given-names>Sander W</given-names></name><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-271344"><name><surname>Killestein</surname><given-names>Joep</given-names></name><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-286314"><name><surname>van Kempen</surname><given-names>Zoé LE</given-names></name><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-271346"><name><surname>Wieske</surname><given-names>Luuk</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2522-4081</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-271347"><name><surname>Kuijpers</surname><given-names>Taco W</given-names></name><xref ref-type="aff" rid="aff11">11</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-271348"><name><surname>Eftimov</surname><given-names>Filip</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-271349"><name><surname>Rispens</surname><given-names>Theo</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-286315"><name><surname>van Ham</surname><given-names>Marieke SM</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-286316"><name><surname>ten Brinke</surname><given-names>Anja</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-271351"><name><surname>van de Sandt</surname><given-names>Carolien E</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4155-7433</contrib-id><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><on-behalf-of>on behalf of the T2B! immunity against SARS-CoV-2 study group</on-behalf-of><aff id="aff1"><institution content-type="dept">Department of Immunopathology</institution>, <institution>Sanquin</institution>, <addr-line><named-content content-type="city">Amsterdam</named-content></addr-line>, <country>Netherlands</country></aff><aff id="aff2"><institution content-type="dept">Department of Hematopoiesis</institution>, <institution>Sanquin</institution>, <addr-line><named-content content-type="city">Amsterdam</named-content></addr-line>, <country>Netherlands</country></aff><aff id="aff3"><institution content-type="dept">Sydney Cytometry Core Research Facility</institution>, <institution>University of Sydney</institution>, <addr-line><named-content content-type="city">Sydney</named-content></addr-line>, <country>Australia</country></aff><aff id="aff4"><institution content-type="dept">Department of Neurology and Neurophysiology</institution>, <institution>Amsterdam University Medical Centers</institution>, <addr-line><named-content content-type="city">Amsterdam</named-content></addr-line>, <country>Netherlands</country></aff><aff id="aff5"><institution content-type="dept">Department of Experimental Immunohematology</institution>, <institution>Sanquin</institution>, <addr-line><named-content content-type="city">Amsterdam</named-content></addr-line>, <country>Netherlands</country></aff><aff id="aff6"><institution content-type="dept">Department of Research Facilities</institution>, <institution>Sanquin</institution>, <addr-line><named-content content-type="city">Amsterdam</named-content></addr-line>, <country>Netherlands</country></aff><aff id="aff7"><institution content-type="dept">Department of Microbiology and Immunology,</institution>, <institution>University of Melbourne</institution>, <addr-line><named-content content-type="city">Melbourne</named-content></addr-line>, <country>Australia</country></aff><aff id="aff8"><institution content-type="dept">Amsterdam Rheumatology and immunology Center</institution>, <institution>Reade</institution>, <addr-line><named-content content-type="city">Amsterdam</named-content></addr-line>, <country>Netherlands</country></aff><aff id="aff9"><institution content-type="dept">Amsterdam Rheumatology and immunology Center</institution>, <institution>Amsterdam University Medical Centers</institution>, <addr-line><named-content content-type="city">Amsterdam</named-content></addr-line>, <country>Netherlands</country></aff><aff id="aff10"><institution content-type="dept">Department of Neurology</institution>, <institution>Amsterdam University Medical Centers</institution>, <addr-line><named-content content-type="city">Amsterdam</named-content></addr-line>, <country>Netherlands</country></aff><aff id="aff11"><institution content-type="dept">Department of Pediatric Immunology</institution>, <institution>Amsterdam University Medical Centers</institution>, <addr-line><named-content content-type="city">Amsterdam</named-content></addr-line>, <country>Netherlands</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-272642"><name><surname>Sasson</surname><given-names>Sarah</given-names></name><role>Reviewing editor</role><aff><institution>The Kirby Institute UNSW</institution>, <country>Australia</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>a.tenbrinke@sanquin.nl</email> (At);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>cvandesandt@unimelb.edu.au</email> (Cv);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>15</day><month>07</month><year>2022</year></pub-date><volume>11</volume><elocation-id>e77969</elocation-id><history><date date-type="received"><day>17</day><month>02</month><year>2022</year></date><date date-type="accepted"><day>14</day><month>07</month><year>2022</year></date></history><permissions><copyright-statement>© 2022, Verstegen et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Verstegen et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-77969-v1.pdf"/><abstract><p><bold>Background:</bold> Patients affected by different types of autoimmune diseases, including common conditions such as Multiple Sclerosis (MS) and Rheumatoid Arthritis (RA), are often treated with immunosuppressants to suppress disease activity. It is not fully understood how the SARS-CoV-2 specific humoral and cellular immunity induced by infection and/or upon vaccination is affected by immunosuppressants.</p><p><bold>Methods:</bold> The dynamics of cellular immune reactivation upon vaccination of SARS-CoV-2 experienced MS patients treated with the humanized anti-CD20 monoclonal antibody ocrelizumab (OCR) and RA patients treated with methotrexate (MTX) monotherapy were analyzed at great depth via high-dimensional flow cytometry of whole blood samples upon vaccination with the SARS-CoV-2 mRNA-1273 (Moderna) vaccine. Longitudinal B and T cell immune responses were compared to SARS-CoV-2 experienced healthy controls (HC) before and 7-days after the first and second vaccination.</p><p><bold>Results:</bold> OCR-treated MS patients exhibit a preserved recall response of CD8<sup>+</sup> T central memory cells following first vaccination compared to healthy controls and a similar CD4<sup>+</sup> circulating T follicular helper 1 and T helper 1 dynamics, whereas humoral and B cell responses were strongly impaired resulting in absence of SARS-CoV-2 specific humoral immunity. MTX treatment significantly delayed antibody levels and B reactivation following the first vaccination, including sustained inhibition of overall reactivation marker dynamics of the responding CD4<sup>+</sup> and CD8<sup>+</sup> T cells.</p><p><bold>Conclusion:</bold> Together, these findings indicate that SARS-CoV-2 experienced MS-OCR patients still benefit from vaccination by inducing a broad CD8<sup>+</sup> T cell response which can contribute to milder disease outcome. A delayed dynamics of vaccine-induced immunological recall in RA-MTX patients support repeated vaccine strategies to protect against future variants of concern, especially for these patients.</p><p><bold>Funding:</bold> This research project was supported by ZonMw (The Netherlands Organization for Health Research and Development, #10430072010007), the European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant agreement (#792532 and #860003), the European Commission (SUPPORT-E, #101015756) and by PPOC (#20_21 L2506), the NHMRC Leadership Investigator Grant (#1173871).</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001826</institution-id><institution>ZonMw</institution></institution-wrap></funding-source><award-id>#10430072010007</award-id><principal-award-recipient><name><surname>Kuijpers</surname><given-names>Taco W</given-names></name><name><surname>Eftimov</surname><given-names>Filip</given-names></name><name><surname>Rispens</surname><given-names>Theo</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010661</institution-id><institution>Horizon 2020 Framework Programme</institution></institution-wrap></funding-source><award-id>#860003</award-id><principal-award-recipient><name><surname>Kuijpers</surname><given-names>Taco W</given-names></name><name><surname>Eftimov</surname><given-names>Filip</given-names></name><name><surname>Rispens</surname><given-names>Theo</given-names></name><name><surname>van de Sandt</surname><given-names>Carolien E</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000780</institution-id><institution>European Commission</institution></institution-wrap></funding-source><award-id>#101015756</award-id><principal-award-recipient><name><surname>Verstegen</surname><given-names>Niels JM</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010661</institution-id><institution>Horizon 2020 Framework Programme</institution></institution-wrap></funding-source><award-id>#792532</award-id><principal-award-recipient><name><surname>van de Sandt</surname><given-names>Carolien E</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution>NHMRC</institution></institution-wrap></funding-source><award-id>1173871</award-id><principal-award-recipient><name><surname>Killestein</surname><given-names>Joep</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution>PPOC</institution></institution-wrap></funding-source><award-id>#20_21 L2506</award-id><principal-award-recipient><name><surname>Kuijpers</surname><given-names>Taco W</given-names></name><name><surname>Eftimov</surname><given-names>Filip</given-names></name><name><surname>Rispens</surname><given-names>Theo</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Joep Killestein, has speaking relationships with Merck, Biogen, TEVA, Sanofi, Genzyme, Roche and Novartis. AmsterdamUMC, location VUmc, MS Center Amsterdam has received financial support for research activities from Merck, Celgene, Biogen, GlaxoSmithKline, Immunic, Roche, Teva, Sanofi, Genzyme, and Novartis..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: This study was approved by the medical ethical committee (NL74974.018.20 and EudraCT 2021-001102-30, local METC nummer: 2020_194) and registered at Dutch Trial Register (Trial ID NL8900). Written informed consent was obtained from all study participants when enrolled. Participants were recruited between April 16th 2021 and May 20th 2021 at the MS Center Amsterdam, Amsterdam UMC and the Amsterdam READE Rheumatology and Immunology Center and vaccinated between April 19th 2021 and July 1st 2021 with the mRNA-1273 (Moderna) vaccine at an interval of six weeks, according to the Dutch national vaccination guidelines.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All raw and processed data presented in this study are available at https://flowrepository.org/id/FR-FCM-Z52K</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Verstegen NJM</collab><collab>Hagen R</collab><collab>van den Dijssel J</collab><collab>Kuijper L</collab><collab>Kreher C</collab><collab>Ashhurst T</collab><collab>Kummer LYL</collab><collab>Steenhuis M</collab><collab>Duurland M</collab><collab>de Jongh R</collab><collab>de Jong N</collab><collab>Bos AV</collab><collab>Kedzierska K</collab><collab>van Dam PJ</collab><collab>Stalman EW</collab><collab>Boekel L</collab><collab>Wolbink GJ</collab><collab>Tas SW</collab><collab>Killestein J</collab><collab>van Kempen ZLE</collab><collab>Wieske L</collab><collab>Kuijpers TW</collab><collab>Eftimov F</collab><collab>Rispens T</collab><collab>van Ham SM</collab><collab>ten Brinke A</collab><collab>van der Sandt CE</collab></person-group><year iso-8601-date="2022">2022</year><source>All raw and processed flow cytometry data</source><ext-link ext-link-type="uri" xlink:href="https://flowrepository.org/id/FR-FCM-Z52K">https://flowrepository.org/id/FR-FCM-Z52K</ext-link><comment>FR-FCM-Z52K</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-77969-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>